Compare EOLS & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | KREF |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.0M | 521.3M |
| IPO Year | 2018 | 2017 |
| Metric | EOLS | KREF |
|---|---|---|
| Price | $5.01 | $8.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $18.80 | $10.63 |
| AVG Volume (30 Days) | ★ 1.4M | 834.7K |
| Earning Date | 03-03-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 12.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $285,823,000.00 | $62,012,000.00 |
| Revenue This Year | $14.00 | $15.35 |
| Revenue Next Year | $16.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.10 | N/A |
| 52 Week Low | $4.74 | $7.55 |
| 52 Week High | $17.12 | $11.53 |
| Indicator | EOLS | KREF |
|---|---|---|
| Relative Strength Index (RSI) | 28.88 | 49.28 |
| Support Level | $4.81 | $7.99 |
| Resistance Level | $5.89 | $8.34 |
| Average True Range (ATR) | 0.39 | 0.25 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 13.79 | 80.12 |
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.